DAVID GORDON: Open Payments
NPI 1760724603 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,663 in 127 payments from 16 companies in 2025. Trend: 2023 $4,647 · 2024 $8,587 · 2025 $2,663
Food & beverage: $2,006Consulting: $638Education: $19
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 44 | $1,188 |
| ABBVIE INC. | 34 | $415 |
| Collegium Pharmaceutical, Inc. | 13 | $203 |
| Abbott Laboratories | 11 | $165 |
| Stryker Corporation | 1 | $145 |
| Saluda Medical Americas, Inc. | 1 | $141 |
| TerSera Therapeutics LLC | 4 | $75 |
| Lundbeck LLC | 3 | $71 |
| Orexo US, Inc. | 3 | $43 |
| Teva Pharmaceuticals USA, Inc. | 3 | $43 |
Products named: WaveWriter Alpha Prime 16, XTAMPZA, BOTOX, PROCLAIM, MILD DEVICE KIT, QULIPTA, Evoke, General - Pain Management.
Industry payments across IN — which companies pay providers there.
